Yantai Yuhuangding Hospital
70
15
18
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 50/100
2.9%
2 terminated/withdrawn out of 70 trials
75.0%
-11.5% vs industry average
23%
16 trials in Phase 3/4
0%
0 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (70)
A Multicenter RCT of "3+7" vs Venetoclax + CACAG in Newly Diagnosed Mid/High-Risk AML Patients
Role: collaborator
Postoperative Adjuvant Therapy for Stage II-III Gastric Cancer
Role: collaborator
The Effect of Oral Clostridium Butyricum on the Recurrence After Colonoscopic Resection of Colorectal Adenoma
Role: collaborator
Laparoscopic Staging for Stage III Gastric Cancer
Role: collaborator
Clinical Study of Venetoclax Combined With CACAG Regimen in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia
Role: collaborator
Laparoscopic Gastrectomy With D2 Lymphadenectomy Combined With Hyperthermic Intraperitoneal Chemotherapy (HIPEC) or Not
Role: collaborator
Early Postoperative Intervention in Gastric Cancer Patients
Role: collaborator
Evaluating the Efficacy of Neoadjuvant Chemotherapy Drugs Based on Organoid Technology
Role: collaborator
Evaluation of the Efficacy of Anti-HER2 Antibody-Drug Conjugates (ADC) in Locally Advanced or Metastatic Bladder Cancer Based on Organoid Technology.
Role: collaborator
Evaluation of Postoperative Adjuvant Chemotherapy Efficacy for Bladder Cancer Based on Organoid Technology.
Role: collaborator
Venetoclax Plus CACAG Regimen for Newly Diagnosed Acute Myeloid Leukemia
Role: collaborator
Isa-VRD in TIE HRMM
Role: collaborator
Efficacy and Safety of Finerenone and Empagliflozin in Delaying Renal Function Progression After Radical Nephrectomy in High-Risk CKD Patients: A Multicenter RCT
Role: collaborator
A Prediction Model in Pregnant Women With Aplastic Anemia
Role: collaborator
Desiccated Thyroid Extract Combined With Levothyroxine for TSH Suppression Therapy in DTC
Role: collaborator
A Prospective, Single-center, Phase II Study of Sacituzumab Tirumotecan in Combination With Pembrolizumab for Neoadjuvant Treatment of Triple-Negative Breast Cancer (TNBC)
Role: lead
The Effects of Clostridium Butyricum on Adverse Events During Adjuvant Chemotherapy for Colorectal Cancer
Role: collaborator
Chinese Ostomy Collaboration Group (COCG) Clinical Study -SITI Classification
Role: collaborator
Epidemiological Study for Bronchopulmonary Dysplasia (BPD) in China
Role: collaborator
Minimal Residual Disease-guided Adjuvant Therapy for Gastric Cancer
Role: collaborator